804
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis

, , &
Pages 445-454 | Published online: 03 Jun 2020

References

  • Umland EM. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Manag Care Pharm. 2008;14(3 Supp A):14–19. doi:10.18553/jmcp.2008.14.S3-A.14
  • Kleinman NL, Rohrbacker NJ, Bushmakin AG, Whiteley J, Lynch WD, Shah SN. Direct and indirect costs of women diagnosed with menopause symptoms. J Occup Environ Med. 2013;55(4):465–470. doi:10.1097/JOM.0b013e3182820515
  • Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63(4):375–382. doi:10.1001/archpsyc.63.4.375
  • Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause. 2002;9(6):392–398. doi:10.1097/00042192-200211000-00003
  • Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Fehnel SE, Clark RV. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas. 2007;58(4):348–358. doi:10.1016/j.maturitas.2007.09.006
  • Berecki-Gisolf J, Begum N, Dobson AJ. Symptoms reported by women in midlife: menopausal transition or aging? Menopause. 2009;16(5):1021–1029. doi:10.1097/gme.0b013e3181a8c49f
  • Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause. 2003;10(6):507–515. doi:10.1097/01.GME.0000064865.58809.3E
  • Reed SD, Ludman EJ, Newton KM, et al. Depressive symptoms and menopausal burden in the midlife. Maturitas. 2009;62(3):306–310. doi:10.1016/j.maturitas.2009.01.002
  • Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric. 2007;10(3):197–214. doi:10.1080/13697130601181486
  • Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause — global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199–215. doi:10.1038/nrendo.2017.180
  • Schoenaker DA, Jackson CA, Rowlands JV, Mishra GD. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int J Epidemiol. 2014;43(5):1542–1562. doi:10.1093/ije/dyu094
  • Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: study of women’s health across the nation. Menopause (New York, NY). 2009;16(5):860–869. doi:10.1097/gme.0b013e3181a3cdaf
  • Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas. 2009;62(2):153–159. doi:10.1016/j.maturitas.2008.12.006
  • Kjerulff KH, Frick KD, Rhoades JA, Hollenbeak CS. The cost of being a woman: a national study of health care utilization and expenditures for female-specific conditions. Womens Health Issues. 2007;17(1):13–21. doi:10.1016/j.whi.2006.11.004
  • Sarrel P, Portman D, Lefebvre P, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015;22(3):260–266. doi:10.1097/GME.0000000000000320
  • Whiteley J, DiBonaventura M, Wagner J-S, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health. 2013;22(11):983–990. doi:10.1089/jwh.2012.3719
  • Israel Central Bureau of Statistics. Characterization and Classification of Geographic Units by the Soci-Economic Level of the Population 2008. Jerusalem, Israel; 2013. Publication No. 1530.
  • Shalev V, Chodick G, Goren I, Silber H, Kokia E, Heymann AD. The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization. Int J Cardiol. 2011;152(3):345–349. doi:10.1016/j.ijcard.2010.08.002
  • Goldshtein I, Chandler J, Shalev V, et al. Osteoporosis in the community: findings from a novel computerized registry in a large health organization in Israel. Aging Res Clin Pract. 2015;4(1):59–65.
  • Chodick G, Heymann AD, Shalev V, Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol. 2003;18(12):1143–1146. doi:10.1023/B:EJEP.0000006635.36802.c8
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619. doi:10.1016/0895-4356(92)90133-8
  • Assaf AR, Bushmakin AG, Joyce N, Louie MJ, Flores M, Moffatt M. The relative burden of menopausal and postmenopausal symptoms versus other major conditions: a retrospective analysis of the medical expenditure panel survey data. Am Health Drug Benefits. 2017;10(6):311–321.
  • Whitcomb BW, Purdue-Smithe AC, Szegda KL, et al. Cigarette smoking and risk of early natural menopause. Am J Epidemiol. 2018;187(4):696–704. doi:10.1093/aje/kwx292
  • Hayatbakhsh MR, Clavarino A, Williams GM, Sina M, Najman JM. Cigarette smoking and age of menopause: a large prospective study. Maturitas. 2012;72(4):346–352. doi:10.1016/j.maturitas.2012.05.004
  • Sun L, Tan L, Yang F, et al. Meta-analysis suggests that smoking is associated with an increased risk of early natural menopause. Menopause. 2012;19(2):126–132. doi:10.1097/gme.0b013e318224f9ac
  • Mishra GD, Chung H-F, Cano A, et al. EMAS position statement: predictors of premature and early natural menopause. Maturitas. 2019;123:82–88. doi:10.1016/j.maturitas.2019.03.008
  • Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas. 2000;35(1):3–9. doi:10.1016/S0378-5122(00)00092-X
  • Ohta H, Sugimoto I, Masuda A, et al. Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women. Bone. 1996;18(3):227–231. doi:10.1016/8756-3282(95)00480-7
  • Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118(12):14–24. doi:10.1016/j.amjmed.2005.09.031
  • Melby MK, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update. 2005;11(5):495–512. doi:10.1093/humupd/dmi018
  • Kaufert P, Syrotuik J. Symptom reporting at the menopause. Soc Sci Med E. 1981;15(3):173–184.
  • Tal A, Roe D, Corrigan PW. Mental illness stigma in the Israeli context: deliberations and suggestions. Int J Soc Psychiatry. 2007;53(6):547–563. doi:10.1177/0020764007082346
  • Guthrie J, Dennerstein L, Taffe J, Donnelly V. Health care-seeking for menopausal problems. Climacteric. 2003;6(2):112–117. doi:10.1080/cmt.6.2.112.117
  • Hess R, Chang C, Ness R, Hays R, Kapoor W, Bryce C, editors. The associations of menopause and health-related quality of life with health services utilization: results from the STRIDE study. Abstract presented at the 32nd Annual Meeting of the Society of Medical Decision Making; 2010; Toronto, Ontario, Canada.
  • Xu J, Bartoces M, Neale AV, Dailey RK, Northrup J, Schwartz KL. Natural history of menopause symptoms in primary care patients: a MetroNet study. J Am Board Fam Med. 2005;18(5):374–382. doi:10.3122/jabfm.18.5.374
  • Antonovsky A. A model to explain visits to the doctor: with specific reference to the case of Israel. J Health Soc Behav. 1972;13(4):446–454. doi:10.2307/2136838
  • Baron‐Epel O, Garty N, Green MS. Inequalities in use of health services among Jews and Arabs in Israel. Health Serv Res. 2007;42(3p1):1008–1019. doi:10.1111/j.1475-6773.2006.00645.x
  • Shyu Y-K, Pan C-H, Liu W-M, Hsueh J-Y, Hsu C-S, Tsai P-S. Health-related quality of life and healthcare resource utilization in Taiwanese women with menopausal symptoms: a nation-wide survey. J Nurs Res. 2012;20(3):208–218. doi:10.1097/jnr.0b013e318265619b
  • Bloch A. Self-awareness during the menopause. Maturitas. 2002;41(1):61–68. doi:10.1016/S0378-5122(01)00252-3
  • Yazdkhasti M, Simbar M, Abdi F. Empowerment and coping strategies in menopause women: a review. Iran Red Crescent Med J. 2015;17(3). doi:10.5812/ircmj.18944
  • Hall L, Callister LC, Berry JA, Matsumura G. Meanings of menopause: cultural influences on perception and management of menopause. J Holist Nurs. 2007;25(2):106–118. doi:10.1177/0898010107299432
  • Hickey M, Szabo RA, Hunter MS. Non-hormonal treatments for menopausal symptoms. BMJ. 2017;359:j5101. doi:10.1136/bmj.j5101
  • Vitale SG, Caruso S, Rapisarda AMC, Cianci S, Cianci A. Isoflavones, calcium, vitamin D and inulin improve quality of life, sexual function, body composition and metabolic parameters in menopausal women: result from a prospective, randomized, placebo-controlled, parallel-group study. Prz Menopauzalny Menopause Rev. 2018;17(1):32. doi:10.5114/pm.2018.73791
  • Lagana AS, Vitale SG, Stojanovska L, et al. Preliminary results of a single-arm pilot study to assess the safety and efficacy of visnadine, prenylflavonoids and bovine colostrum in postmenopausal sexually active women affected by vulvovaginal atrophy. Maturitas. 2018;109:78–80. doi:10.1016/j.maturitas.2017.12.015
  • Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008;299(9):1036–1045. doi:10.1001/jama.299.9.1036
  • Collaborators MWS. Breast cancer and hormone-replacement therapy in the million women study. Lancet. 2003;362(9382):419–427.
  • Lobo RA. Hormone-replacement therapy: current thinking. Nat Rev Endocrinol. 2017;13(4):220. doi:10.1038/nrendo.2016.164
  • NICE. UK. [updated January 22, 2019]. Available from: https://www.nice.org.uk/guidance/ng23. Accessed May 13, 2020.
  • Rees M. Alternative treatments for the menopause. Best Pract Res Clin Obstet Gynaecol. 2009;23(1):151–161. doi:10.1016/j.bpobgyn.2008.10.006
  • Moore TR, Franks RB, Fox C. Review of efficacy of complementary and alternative medicine treatments for menopausal symptoms. J Midwifery Womens Health. 2017;62(3):286–297. doi:10.1111/jmwh.12628
  • Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988;26(8):814–823. doi:10.1097/00005650-198808000-00007